"We have previously shown that verapamil can prevent diabetes and even reverse the disease in mouse models and reduce TXNIP in human islet beta cells, suggesting that it may have beneficial effects in humans as well," Dr. Anath Shalev, director of UAB's Comprehensive Diabetes Center and principal investigator of the verapamil clinical trial.